What criteria determine which stories make the weekly roundup?

Stories qualify for the weekly roundup based on three criteria: (1) financial materiality exceeding $500M in deal value or market impact, (2) precedent-setting regulatory or policy action, or (3) strategic signal that changes competitive dynamics in a major therapeutic category. Routine FDA approvals, incremental data updates, and minor personnel changes are covered in section-specific coverage but not the weekly synthesis.